This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Russell, A. D.
Right arrow Articles by Furr, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Russell, A. D.
Right arrow Articles by Furr, J. R.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 1998, p. 2151-2151, Vol. 42, No. 8
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

LETTERS TO THE EDITOR

Possible Link between Bacterial Resistance and Use of Antibiotics and Biocides

    LETTER
Top
Letter
References

Low-level plasmid-mediated resistance to cationic biocides such as chlorhexidine (CHX), quaternary ammonium compounds (QACs), amidines, and acridines has been observed in antibiotic-resistant strains of Staphylococcus aureus and Staphylococcus epidermidis (1, 4, 5), and it has been postulated that strains in which qac genes are present might have enhanced survival in the clinical environment. Extensive use of cationic biocides could lead to the selection of staphylococcal strains showing resistance to both antibiotics and biocides (9, 11), but the clinical relevance of this possibility remains contentious (8).

Although plasmid-mediated resistance to biocides has also been found in gram-negative bacteria, it has been proposed (8) that intrinsic resistance in these organisms is of greater significance. Resistance to both antibiotics and biocides in gram-negative organisms is more likely where less specific mechanisms are involved, e.g., the outer membrane may act as a nonspecific exclusion blanket thereby preventing the uptake of chemically unrelated molecules (10, 11). There have, however, been some instances where biocides have been claimed to select for resistant gram-negative bacteria. Stickler et al. (12) observed resistance to CHX, QACs and at least five antibiotics for gram-negative bacteria isolated from urinary tract infections and proposed that the widespread use of CHX was responsible for selecting antibiotic-resistant strains. There was no evidence of plasmid-linked resistance association (although the possibility was raised but not proven that CHX-resistant strains were acting as more efficient recipients of plasmids conferring antibiotic resistance). Dance et al. (2) isolated a strain of Proteus mirabilis, responsible for a hospital outbreak, that was resistant to CHX and antibiotics. However, there was no evidence of a genetic linkage between these resistances, which were considered to be intrinsic rather than plasmid mediated. Selection of antibiotic-resistant bacteria by chlorination of drinking water and treated sewage has also been described, and the basis of linked biocide-antibiotic resistance in organisms isolated from aquatic sources is of potential public health importance (9).

We have developed stable CHX resistance in some strains of Pseudomonas stutzeri by exposure to increasing concentrations of the bisbiguanide. MICs of CHX for parent strains were 2.5 to 5 µg/ml and MICs for resistant strains were 10 to 100 µg/ml. The CHX-resistant strains showed a variable increase in resistance to QACs (benzalkonium chloride and cetylpyridinium chloride) and to triclosan (increases in MICs of the phenolic of 25- to 250-fold). Additionally, these CHX-resistant strains also demonstrated a variable increase in resistance to polymyxin B, gentamicin, nalidixic acid, erythromycin, and ampicillin (Table 1). Resistant cells took up less CHX from solution than susceptible cells and cell envelope changes were observed microscopically, implicating the outer membrane as being involved in this reduced susceptibility.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   Responses of CHX-susceptible and CHX-resistant strains of P. stutzeri to other antibacterial agents

Moken et al. (6) have described the selection of low-level chromosomal antibiotic resistance in Escherichia coli following exposure to a sublethal concentration of pine oil and have demonstrated that an export resistance mechanism (3) was involved. They also found that deletion of acrAB, but not of mar, resulted in a >10-fold increase in susceptibility of strains to a QAC and to chloroxylenol and thereby surmised that acrAB was also involved in efflux of these two biocides.

Concern about a possible linkage between antibiotic and biocide resistance has again been expressed recently (7) and clearly needs to be considered further in a clinical context. It is likely that more than one type of mechanism, viz., outer membrane changes and efflux, is involved.

    REFERENCES
Top
Letter
References

1. Behr, H., M. E. Reverdy, C. Mabilat, J. Freney, and J. Fleurette. 1994. Relation entre le niveau des concentrations minimales inhibitrices de cinq antiseptiques et la présence du gène qacA chez Staphylococcus aureus. Pathol. Biol. 42:438-444[Medline].
2. Dance, D. A. B., A. D. Pearson, D. V. Seal, and J. A. Lowes. 1987. A hospital outbreak caused by a chlorhexidine and antibiotic resistant Proteus mirabilis. J. Hosp. Infect. 10:10-16[Medline].
3. George, A. M. 1996. Multidrug resistance in enteric and other Gram-negative bacteria. FEMS Microbiol. Lett. 139:1-10[Medline].
4. Leelaporn, A., I. T. Paulsen, J. M. Tennent, T. G. Littlejohn, and R. A. Skurray. 1994. Multidrug resistance to antiseptics and disinfectants in coagulase-negative staphylococci. J. Med. Microbiol. 40:214-220[Abstract/Free Full Text].
5. Lyon, B. R., and R. A. Skurray. 1987. Antimicrobial resistance of Staphyloccus aureus: genetic basis. Microbiol. Rev. 51:88-134[Free Full Text].
6. Moken, M. C., L. M. McMurry, and S. B. Levy. 1997. Selection of multiple antibiotic-resistant (Mar) mutants of Escherichia coli by using the disinfectant pine oil: roles of the mar and AcrAB loci. Antimicrob. Agents Chemother. 41:2770-2772[Abstract].
7. Royal Pharmaceutical Society of Great Britain. 1997. Resistance to antimicrobial agents: submission to House of Lords subcommittee. Pharm. J. 259:919-921.
8. Russell, A. D. 1997. Plasmids and bacterial resistance to biocides. J. Appl. Microbiol. 82:155-165.
9. Russell, A. D., and I. Chopra. 1996. Understanding antibacterial action and resistance, p. 226-237. , 266-269. Ellis Horwood, Chichester, United Kingdom.
10. Russell, A. D., J. R. Furr, and J.-Y. Maillard. 1997. Microbial susceptibility and resistance to biocides. ASM News 63:481-487.
11. Russell, A. D., and N. J. Russell. 1995. Biocides: activity, action and resistance, p. 327-365. In P. A. Hunter, G. K. Darby, and N. J. Russell (ed.), Fifty years of antimicrobials: past perspectives and future trends. 53rd Symposium of the Society for General Microbiology. Cambridge University Press, Cambridge, United Kingdom.
12. Stickler, D. J., B. Thomas, J. C. Clayton, and J. A. Chawla. 1983. Studies on the genetic basis of chlorhexidine resistance. Brit. J. Clin. Prac. Symp. 25(Suppl.):23-28.
A. D. Russell
Unchalee Tattawasart
J.-Y. Maillard
J. R. Furr
Welsh School of Pharmacy
University of Wales Cardiff
Cardiff CF1 3XF
United Kingdom


Antimicrobial Agents and Chemotherapy, August 1998, p. 2151-2151, Vol. 42, No. 8
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Zaidi, A. H., Bakkes, P. J., Lubelski, J., Agustiandari, H., Kuipers, O. P., Driessen, A. J. M. (2008). The ABC-Type Multidrug Resistance Transporter LmrCD Is Responsible for an Extrusion-Based Mechanism of Bile Acid Resistance in Lactococcus lactis. J. Bacteriol. 190: 7357-7366 [Abstract] [Full Text]  
  • Dong, L., Yan, H., Wang, D. (2008). Antibiotic prescribing patterns in village health clinics across 10 provinces of Western China. J Antimicrob Chemother 62: 410-415 [Abstract] [Full Text]  
  • Kawamura-Sato, K., Wachino, J.-i., Kondo, T., Ito, H., Arakawa, Y. (2008). Reduction of disinfectant bactericidal activities in clinically isolated Acinetobacter species in the presence of organic material. J Antimicrob Chemother 61: 568-576 [Abstract] [Full Text]  
  • Vali, L., Davies, S. E., Lai, L. L. G., Dave, J., Amyes, S. G. B. (2008). Frequency of biocide resistance genes, antibiotic resistance and the effect of chlorhexidine exposure on clinical methicillin-resistant Staphylococcus aureus isolates. J Antimicrob Chemother 61: 524-532 [Abstract] [Full Text]  
  • Mangalappalli-Illathu, A. K., Korber, D. R. (2006). Adaptive Resistance and Differential Protein Expression of Salmonella enterica Serovar Enteritidis Biofilms Exposed to Benzalkonium Chloride. Antimicrob. Agents Chemother. 50: 3588-3596 [Abstract] [Full Text]  
  • Gilbert, P., McBain, A. J. (2003). Potential Impact of Increased Use of Biocides in Consumer Products on Prevalence of Antibiotic Resistance. Clin. Microbiol. Rev. 16: 189-208 [Abstract] [Full Text]  
  • Loughlin, M. F., Jones, M. V., Lambert, P. A. (2002). Pseudomonas aeruginosa cells adapted to benzalkonium chloride show resistance to other membrane-active agents but not to clinically relevant antibiotics. J Antimicrob Chemother 49: 631-639 [Abstract] [Full Text]  
  • Levy, S. B. (2002). Factors impacting on the problem of antibiotic resistance. J Antimicrob Chemother 49: 25-30 [Abstract] [Full Text]  
  • Tambe, S. M., Sampath, L., Modak, S. M. (2001). In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. J Antimicrob Chemother 47: 589-598 [Abstract] [Full Text]  
  • Tattawasart, U., Hann, A. C., Maillard, J.-Y., Furr, J. R., Russell, A. D. (2000). Cytological changes in chlorhexidine-resistant isolates of Pseudomonas stutzeri. J Antimicrob Chemother 45: 145-152 [Abstract] [Full Text]  
  • Ryder, M. (1999). The Future of Vascular Access: Will the Benefits Be Worth the Risk?. Nutr Clin Pract 14: 165-169  

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Russell, A. D.
Right arrow Articles by Furr, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Russell, A. D.
Right arrow Articles by Furr, J. R.